These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1007 related items for PubMed ID: 24449318

  • 1. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
    Schultz NA, Dehlendorff C, Jensen BV, Bjerregaard JK, Nielsen KR, Bojesen SE, Calatayud D, Nielsen SE, Yilmaz M, Holländer NH, Andersen KK, Johansen JS.
    JAMA; ; 311(4):392-404. PubMed ID: 24449318
    [Abstract] [Full Text] [Related]

  • 2. Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study.
    Cao Z, Liu C, Xu J, You L, Wang C, Lou W, Sun B, Miao Y, Liu X, Wang X, Zhang T, Zhao Y.
    Oncotarget; 2016 Jul 05; 7(27):41575-41583. PubMed ID: 27223429
    [Abstract] [Full Text] [Related]

  • 3. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer.
    Wang WS, Liu LX, Li GP, Chen Y, Li CY, Jin DY, Wang XL.
    Cancer Prev Res (Phila); 2013 Apr 05; 6(4):331-8. PubMed ID: 23430754
    [Abstract] [Full Text] [Related]

  • 4. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer.
    Liu J, Gao J, Du Y, Li Z, Ren Y, Gu J, Wang X, Gong Y, Wang W, Kong X.
    Int J Cancer; 2012 Aug 01; 131(3):683-91. PubMed ID: 21913185
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The potential diagnostic value of serum microRNA signature in patients with pancreatic cancer.
    Johansen JS, Calatayud D, Albieri V, Schultz NA, Dehlendorff C, Werner J, Jensen BV, Pfeiffer P, Bojesen SE, Giese N, Nielsen KR, Nielsen SE, Yilmaz M, Holländer NH, Andersen KK.
    Int J Cancer; 2016 Nov 15; 139(10):2312-24. PubMed ID: 27464352
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis.
    Su SB, Qin SY, Chen W, Luo W, Jiang HX.
    World J Gastroenterol; 2015 Apr 14; 21(14):4323-33. PubMed ID: 25892884
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Mayerle J, Kalthoff H, Reszka R, Kamlage B, Peter E, Schniewind B, González Maldonado S, Pilarsky C, Heidecke CD, Schatz P, Distler M, Scheiber JA, Mahajan UM, Weiss FU, Grützmann R, Lerch MM.
    Gut; 2018 Jan 14; 67(1):128-137. PubMed ID: 28108468
    [Abstract] [Full Text] [Related]

  • 17. Identification of Serum microRNA-25 as a novel biomarker for pancreatic cancer.
    Yu Y, Tong Y, Zhong A, Wang Y, Lu R, Guo L.
    Medicine (Baltimore); 2020 Dec 24; 99(52):e23863. PubMed ID: 33350781
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer.
    Dittmar RL, Liu S, Tai MC, Rajapakshe K, Huang Y, Longton G, DeCapite C, Hurd MW, Paris PL, Kirkwood KS, Coarfa C, Maitra A, Brand RE, Killary AM, Sen S.
    Cancer Prev Res (Phila); 2021 Jul 24; 14(7):729-740. PubMed ID: 33893071
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.